Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Med ; 9(9)2020 Aug 24.
Article in English | MEDLINE | ID: mdl-32846987

ABSTRACT

Major depressive disorder (MDD) affects approximately 4.4% of the world's population. One third of MDD patients do not respond to routine psychotherapeutic and pharmacotherapeutic treatment and are said to suffer from treatment-resistant depression (TRD). Deep brain stimulation (DBS) is increasingly being investigated as a treatment modality for TRD. Although early case studies showed promising results of DBS, open-label trials and placebo-controlled studies have reported inconsistent outcomes. This has raised discussion about the correct interpretation of trial results as well as the criteria for patient selection, the choice of stimulation target, and the optimal stimulation parameters. In this narrative review, we summarize recent studies of the effectiveness of DBS in TRD and address the relation between the targeted brain structures and clinical outcomes. Elaborating upon that, we hypothesize that the effectiveness of DBS in TRD can be increased by a more personalized and symptom-based approach. This may be achieved by using resting-state connectivity mapping for neurophysiological subtyping of TRD, by using individualized tractography to help decisions about stimulation target and electrode placement, and by using a more detailed registration of symptomatic improvements during DBS, for instance by using 'experience sampling' methods.

2.
Brain Res Bull ; 152: 184-190, 2019 10.
Article in English | MEDLINE | ID: mdl-31325598

ABSTRACT

BACKGROUND: The transient receptor potential vanilloid subtype-1 (TRPV1) channel is a calcium selective ion channel that responds to various stimuli such as heat, low pH, and capsaicin. Recently this channel was studied as an actuator for wireless neuromodulation in rodents, e.g., heat-induced activation of TRPV1 resulted in neuronal excitation. From a translational perspective, we addressed if TRPV1 is endogenously expressed in the human medial frontal gyrus (MFG) and cingulate gyrus (CG) in depressed and control subjects and if it can be used as a means for neuromodulation in mood and other neuropsychiatric disorders. METHODS: We assessed TRPV1 expression levels by Western blotting and evaluated its tissue and cellular distribution by means of immunohistochemistry. RESULTS: TRPV1 was observed in all tissue samples, i.e., depressed and control, MFG and CG, yet the expression level as assessed by Western blotting varied between individuals. No intra-individual differences were seen between the MFG and CG. Immunohistochemistry showed that TRPV1 was expressed by glial-like cells but also in neurites, endothelial cells, and to a lesser extent in neuronal cell bodies. Fluorescent co-labeling of TRPV1 and glial fibrillary acidic protein (GFAP) identified most glial cells expressing TRPV1 to be astrocytes. CONCLUSION: These findings indicate that TRPV1 is endogenously expressed in the human CG and MFG. As TRPV1 is predominantly expressed by glial cells, this may suggest an opportunity for non-neuronal network modulation.


Subject(s)
Depression/metabolism , Prefrontal Cortex/metabolism , TRPV Cation Channels/biosynthesis , Aged , Aged, 80 and over , Astrocytes/metabolism , Blotting, Western , Calcium/metabolism , Depression/genetics , Depressive Disorder/genetics , Depressive Disorder/metabolism , Endothelial Cells/metabolism , Female , Ganglia, Spinal/metabolism , Gene Expression , Gyrus Cinguli/metabolism , Humans , Male , Neurons/metabolism , TRPV Cation Channels/genetics , TRPV Cation Channels/metabolism , Transcriptome
3.
Prog Neurobiol ; 177: 1-14, 2019 06.
Article in English | MEDLINE | ID: mdl-30878723

ABSTRACT

The field of neuromodulation is developing rapidly. Current techniques, however, are still limited as they i) either depend on permanent implants, ii) require invasive procedures, iii) are not cell-type specific, iv) involve slow pharmacokinetics or v) have a restricted penetration depth making it difficult to stimulate regions deep within the brain. Refinements into the different fields of neuromodulation are thus needed. In this review, we will provide background information on the different techniques of neuromodulation discussing their latest refinements and future potentials including the implementation of nanoparticles (NPs). In particular we will highlight the usage of magnetic nanoparticles (MNPs) as transducers in advanced neuromodulation. When exposed to an alternating magnetic field (AMF), certain MNPs can generate heat through hysteresis. This MNP heating has been promising in the field of cancer therapy and has recently been introduced as a method for remote and wireless neuromodulation. This indicates that MNPs may aid in the exploration of brain functions via neuromodulation and may eventually be applied for treatment of neuropsychiatric disorders. We will address the materials chemistry of MNPs, their biomedical applications, their delivery into the brain, their mechanisms of stimulation with emphasis on MNP heating and their remote control in living tissue. The final section compares and discusses the parameters used for MNP heating in brain cancer treatment and neuromodulation. Concluding, using MNPs for nanomaterial-mediated neuromodulation seem promising in a variety of techniques and could be applied for different neuropsychiatric disorders when more extensively investigated.


Subject(s)
Brain , Electric Stimulation Therapy/methods , Electric Stimulation Therapy/trends , Magnetite Nanoparticles/therapeutic use , Animals , Humans
4.
Epilepsy Behav ; 92: 269-275, 2019 03.
Article in English | MEDLINE | ID: mdl-30731292

ABSTRACT

Deep brain stimulation (DBS) has shown to have antidepressant effects in both human trials and animal studies. However, the optimal target and the underlying therapeutic mechanisms remain to be determined. In this study, we investigated if high frequency (HF) DBS in the dorsal peduncular cortex (DPC) alleviates depressive-like behavior in an experimental model of depression. Surprisingly, HF DBS in the DPC caused acute induction of seizures in ~40% of animals stimulated with clinically relevant stimulation parameters. Reducing the stimulation's amplitude by 50% did not alter seizure occurrence. Electroencephalographic (EEG) recordings showed seizures up to Racine stage IV lasting up to 4 min after cessation of stimulation. We conclude that HF DBS in the DPC is not suitable for mood-related experiments in rats but could be a potential model for seizure induction.


Subject(s)
Cerebral Cortex/physiopathology , Cerebral Peduncle/physiopathology , Deep Brain Stimulation/adverse effects , Depression/physiopathology , Disease Models, Animal , Seizures/physiopathology , Animals , Deep Brain Stimulation/methods , Depression/therapy , Exploratory Behavior/physiology , Male , Rats , Rats, Sprague-Dawley , Seizures/etiology
5.
Neuromodulation ; 22(4): 416-424, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30102446

ABSTRACT

BACKGROUND: Neuromodulation is a promising treatment modality for tinnitus, especially in chronic and severe cases. The auditory thalamus plays a key role in the pathophysiology of tinnitus, as it integrates and processes auditory and limbic information. OBJECTIVE: The effect of high frequency stimulation and low frequency stimulation of the medial geniculate bodies on tinnitus in a noise-induced tinnitus rat model is assessed. MATERIALS AND METHODS: Presence of tinnitus was verified using the gap-induced prepulse inhibition of the acoustic startle response paradigm. Hearing thresholds were determined before and after noise trauma with auditory brainstem responses. Anxiety-related side-effects were evaluated in the elevated zero maze and open field. RESULTS: Results show tinnitus development after noise exposure and preserved hearing thresholds of the ear that was protected from noise trauma. We found that high frequency stimulation of the medial geniculate bodies suppressed tinnitus. This effect maintained directly after stimulation when the stimulator was turned off. Low frequency stimulation did not have any effects on the gap:no-gap ratio of the acoustic startle response. CONCLUSION: High frequency stimulation of the MGB has a direct and residual suppressing effect on tinnitus in this animal model. Low frequency stimulation of the MGB did not inhibit tinnitus.


Subject(s)
Acoustic Stimulation/adverse effects , Deep Brain Stimulation/methods , Disease Models, Animal , Geniculate Bodies/physiopathology , Tinnitus/prevention & control , Tinnitus/physiopathology , Animals , Evoked Potentials, Auditory/physiology , Evoked Potentials, Auditory, Brain Stem/physiology , Male , Rats , Rats, Sprague-Dawley
6.
Springerplus ; 5(1): 1927, 2016.
Article in English | MEDLINE | ID: mdl-27917333

ABSTRACT

Calcification of the ligamentum flavum (CLF) can cause myelopathy due to spinal cord compression. Only several cases in Caucasian patients have been described. Neurological deterioration can only be stopped by surgical decompression. We report a 63-year-old Caucasian woman presenting with progressive pins-and-needles sensations in both hands, worsened by painful paresthesia in both lower extremities. MRI showed a dorsal compressive mass extending from C2 to Th3 vertebrae with myelopathy at the level of C6. A laminectomy was performed, which improved clinical symptoms. Histological examination showed CLF. Early recognition of CLF and early spinal cord decompression are needed to improve neurological outcome.

SELECTION OF CITATIONS
SEARCH DETAIL
...